IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSE
疫苗反应的免疫遗传学机制
基本信息
- 批准号:6497390
- 负责人:
- 金额:$ 35.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-02-01 至 2006-01-31
- 项目状态:已结题
- 来源:
- 关键词:Rubivirus active immunization adolescence (12-20) antiviral antibody clinical research genetic polymorphism histocompatibility gene human subject human therapy evaluation immunogenetics live vaccine measles vaccine measles virus microorganism immunology middle childhood (6-11) mumps virus preschool child (1-5) viral vaccines
项目摘要
DESCRIPTION: Our broad, long term objective is to determine the genetic
mechanisms that influence the immune response (antibody level and
lymphoproliferative responses) to viral vaccines. We propose to study the
influence of HLA class I and II genes on the immune response to an established
live viral vaccine - rubella - as a model. We will also determine whether these
findings are specific to rubella or generalizable to concomitantly administered
live viral (measles and mumps) vaccines. Our central hypothesis is that genetic
polymorphisms of the HLA system significantly influence the immune responses to
live viral vaccines. To test our specific hypotheses, we propose studies with
the following Specific Aims: 1) To estimate the association between specific
alleles of HLA class I alleles (A, B, and C), and immune responses following
rubella immunization in human subjects, 2) To estimate the association between
specific alleles of HLA class II alleles (DRB, DQA, DQB, DPA, and DPB), and
immune responses following rubella immunization, 3) To estimate the effects of
genetic variation (homozygosity and multigenic interactions) across the class I
and/or class II HLA alleles and immune responses following rubella
immunization, and 4) To determine the specificity of vaccine-induced immune
response associations (antibody and lymphoproliferative responses) following
immunization with rubella vaccine compared to models of other live viral
vaccines (measles and mumps). The study aims of this research proposal extend
our NO 1 and RU 1 data on measles vaccine immunogenetics by examining the
influence of the class I (A, B, C) and II (DRB, DQA, DQB, DPA, DPB) HLA genes
upon variations in immune response (defined as antibody levels and
lymphoproliferative responses) following rubella immunization. Our findings may
allow generalizable immunogenetic conclusions regarding the immune response to
viral vaccines. Our study may also guide the development of new vaccines (HIV,
HPV, Hepatitis C, and others) and would facilitate identification of the actual
epitopes involved in immune response variation in a genetically outbred
heterogeneous population.
描述:我们广泛的,长期的目标是确定遗传
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory A. Poland其他文献
The role of mass spectrometry in vaccine development.
质谱在疫苗开发中的作用。
- DOI:
10.1016/s0264-410x(00)00505-3 - 发表时间:
2001 - 期刊:
- 影响因子:5.5
- 作者:
Gregory A. Poland;I. Ovsyannikova;Kenneth L. Johnson;Stephen Naylor - 通讯作者:
Stephen Naylor
Celebrating vaccines: The 2023 Nobel prize in medicine or physiology.
庆祝疫苗:2023 年诺贝尔医学或生理学奖。
- DOI:
10.1016/j.vaccine.2023.10.056 - 发表时间:
2024 - 期刊:
- 影响因子:5.5
- 作者:
Gregory A. Poland;C. Raina Macintyre - 通讯作者:
C. Raina Macintyre
729. Phase I Trial of Intraperitoneal (IP) Administration of a Measles Virus (MV) Strain Expressing the Human Carcinoembryonic Antigen (CEA) in Ovarian Cancer Patients
- DOI:
10.1016/j.ymthe.2006.08.809 - 发表时间:
2006-01-01 - 期刊:
- 影响因子:
- 作者:
Evanthia Galanis;Lynn C. Hartmann;William A. Cliby;Paula Zollman;Prema P. Peethambaram;Harry J. Long;Judith S. Kaur;Jeff A. Sloan;Gregory A. Poland;Kah-Whye Peng;Stephen J. Russell - 通讯作者:
Stephen J. Russell
Trauma-Informed Immunization Practices: A New and Transformative Approach to Vaccine Hesitancy and a Call to Action
创伤知情免疫接种实践:应对疫苗犹豫的一种新的变革性方法及行动呼吁
- DOI:
10.1016/j.mayocp.2024.12.001 - 发表时间:
2025-02-01 - 期刊:
- 影响因子:6.700
- 作者:
Caroline M. Poland;Tamar Ratishvili;Gregory A. Poland - 通讯作者:
Gregory A. Poland
Real-world effectiveness of COVID-19 vaccine in people with HIV compared with a matched HIV-negative cohort: A test-negative design
- DOI:
10.1016/j.ijid.2024.107310 - 发表时间:
2025-01-01 - 期刊:
- 影响因子:
- 作者:
Xueying Yang;Jiajia Zhang;Ziang Liu;Shujie Chen;Sharon Weissman;Gregory A. Poland;Refilwe Nancy Phaswana-Mafuya;Bankole Olatosi;Xiaoming Li - 通讯作者:
Xiaoming Li
Gregory A. Poland的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory A. Poland', 18)}}的其他基金
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
甲型 H1N1 流感疫苗免疫分析的生物信息学方法
- 批准号:
8296557 - 财政年份:2011
- 资助金额:
$ 35.28万 - 项目类别:
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
甲型 H1N1 流感疫苗免疫分析的生物信息学方法
- 批准号:
8695082 - 财政年份:2011
- 资助金额:
$ 35.28万 - 项目类别:
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
甲型 H1N1 流感疫苗免疫分析的生物信息学方法
- 批准号:
8509586 - 财政年份:2011
- 资助金额:
$ 35.28万 - 项目类别:
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
甲型 H1N1 流感疫苗免疫分析的生物信息学方法
- 批准号:
8121282 - 财政年份:2011
- 资助金额:
$ 35.28万 - 项目类别:
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
甲型 H1N1 流感疫苗免疫分析的生物信息学方法
- 批准号:
9118445 - 财政年份:2011
- 资助金额:
$ 35.28万 - 项目类别:
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
甲型 H1N1 流感疫苗免疫分析的生物信息学方法
- 批准号:
7962443 - 财政年份:2010
- 资助金额:
$ 35.28万 - 项目类别:
TRIAL OF RPA102 VACCINE IN HEALTHY ADULT VOLUNTEERS
RPA102 疫苗在健康成年志愿者中的试验
- 批准号:
7206213 - 财政年份:2005
- 资助金额:
$ 35.28万 - 项目类别:
ANTHRAX VACCINE ABSORBED (AVA): A HUMAN REACTOGENICITY AND IMMUNOGENICITY TRIAL
炭疽疫苗吸收 (AVA):人体反应性和免疫原性试验
- 批准号:
7206097 - 财政年份:2005
- 资助金额:
$ 35.28万 - 项目类别:
POPULATION GENETICS ANALYSIS PROGRAM: IMMUNITY TO VACCINES/INFECTIONS
群体遗传学分析项目:疫苗/感染的免疫力
- 批准号:
7543659 - 财政年份:2004
- 资助金额:
$ 35.28万 - 项目类别:
Anthrax Vaccine Absorbed--Human Reactogenicity Trial
炭疽疫苗被吸收--人体反应原性试验
- 批准号:
7042301 - 财政年份:2003
- 资助金额:
$ 35.28万 - 项目类别:
相似海外基金
Active immunization mouse model by cN1A peptides
cN1A肽主动免疫小鼠模型
- 批准号:
18K15370 - 财政年份:2018
- 资助金额:
$ 35.28万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an efficient oocyte collection method using active immunization against inhibin in cynomolgus monkeys.
使用食蟹猴主动免疫抑制素开发有效的卵母细胞收集方法。
- 批准号:
17H06766 - 财政年份:2017
- 资助金额:
$ 35.28万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Passive and Active Immunization for Pneumocystis
肺孢子虫的被动和主动免疫
- 批准号:
9182862 - 财政年份:2015
- 资助金额:
$ 35.28万 - 项目类别:
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
- 批准号:
8136035 - 财政年份:2007
- 资助金额:
$ 35.28万 - 项目类别:
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
- 批准号:
7921670 - 财政年份:2007
- 资助金额:
$ 35.28万 - 项目类别:
Can passive or active immunization alter the course of infection with circoviral DNA?
被动或主动免疫可以改变圆环病毒 DNA 的感染过程吗?
- 批准号:
306844-2004 - 财政年份:2007
- 资助金额:
$ 35.28万 - 项目类别:
Special Research Opportunity Program - Project
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
- 批准号:
7502083 - 财政年份:2007
- 资助金额:
$ 35.28万 - 项目类别:
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
- 批准号:
7341002 - 财政年份:2007
- 资助金额:
$ 35.28万 - 项目类别:
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
- 批准号:
7679096 - 财政年份:2007
- 资助金额:
$ 35.28万 - 项目类别:
Passive-Active Immunization Strategies Against Pediatric AIDS
针对儿童艾滋病的被动-主动免疫策略
- 批准号:
7065729 - 财政年份:2006
- 资助金额:
$ 35.28万 - 项目类别: